Walleye Trading
AUPH icon

Walleye Trading’s Aurinia Pharmaceuticals AUPH Stock Holding History

Walleye Trading’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,236
Closed -$62.8K – 3976
2026
Q1 		$62.8K Sell
4,236
-1,867
-31% -$27.3K ﹤0.01% 3619
2025
Q4 		$97.3K Buy
+6,103
New +$86.5K ﹤0.01% 3746
2024
Q1 		– Sell
-1,560
Closed -$10.6K – 4741
2023
Q4 		$14K Sell
1,560
-27,696
-95% -$228K ﹤0.01% 4561
2023
Q3 		$227K Buy
+29,256
New +$286K ﹤0.01% 3524
2023
Q2 		– Sell
-129,080
Closed -$1.41M – 4693
2023
Q1 		$1.41M Buy
+129,080
New +$1.14M ﹤0.01% 1939
2022
Q4 		– Sell
-69,590
Closed -$404K – 4949
2022
Q3 		$523K Buy
69,590
+14,516
+26% +$126K ﹤0.01% 2868
2022
Q2 		$553K Buy
55,074
+29,886
+119% +$334K ﹤0.01% 2800
2022
Q1 		$312K Buy
25,188
+11,627
+86% +$180K ﹤0.01% 3411
2021
Q4 		$310K Sell
13,561
-64,821
-83% -$1.54M ﹤0.01% 3451
2021
Q3 		$1.74M Buy
78,382
+66,579
+564% +$1.06M 0.01% 1734
2021
Q2 		$153K Buy
+11,803
New +$150K ﹤0.01% 4128
2020
Q3 		– Sell
-13,487
Closed -$219K – 4077
2020
Q2 		$219K Buy
13,487
+1,065
+9% +$17.1K ﹤0.01% 2999
2020
Q1 		$180K Buy
+12,422
New +$219K ﹤0.01% 2692
2019
Q3 		– Sell
-9,425
Closed -$57K – 4006
2019
Q2 		$62K Buy
+9,425
New +$60.1K ﹤0.01% 3468

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's AUPH Position: Q2 2026 in Review

Walleye Trading sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 4,236 shares — an estimated $62.8K sold.

Walleye Trading first reported a position in AUPH in Q2 2019 and held it in 14 quarters. The position peaked at $1.74M in Q3 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Walleye Trading reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 4,236 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $62.8K.
  • Walleye Trading first reported a position in Aurinia Pharmaceuticals in Q2 2019 and held it in 14 quarters.
  • Walleye Trading's Aurinia Pharmaceuticals position peaked at $1.74M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.